• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Analysis-Europe’s record IPO year has a sting in its tail

October 8, 2021 by David Barret Leave a Comment

October 8, 2021

By Abhinav Ramnarayan and Oliver Hirt

LONDON (Reuters) – Europe’s record year for initial public offerings (IPOs) is threatening to come to a juddering halt as inflation fears and concerns over a property crisis in China have soured investors’ appetite for new stock listings.

Deal cancellations and postponements have started to hit the screens with France’s Icade Sante and Switzerland’s Chronext pulling deals in the past week.

Czech company Eurowag pushed through a reduced-size London IPO on Friday, but the trucking services group’s stock fell 10% from its 150 pence offer price.

Many companies that listed earlier in the year are trading below their IPO price, with the FTSE Renaissance IPO Index for the Europe, Middle East and Africa region down 9.19% so far this year.

“Fear of inflation and rising interest rates, as well as uncertainty around China, have made many investors more cautious,” said Christoph Lang, head of core equities in Europe for J. Safra Sarasin. “The Goldilocks environment we had for the last twelve months is over.”

The United States has also been hit by the shift in investors’ mood, with Peleton rival iFIT dropping its IPO plans, while shares in fitness centre operator Life Time’s opened 8% below their offer price on its debut.,

This contrasts with the first nine months of 2021, when listings surged to their the highest level since the dotcom bubble of 2000, based on Refinitiv data, even if the pace slowed in the third quarter.

The IPO market closely reflects investors’ appetite for risk and they tend to become more reluctant to commit large chunks of cash to a single company if the broader economic environment is showing signs of strain.

Uncertainty over the fate of heavily indebted Chinese property company Evergrande and rising bond yields on the back of strong inflation numbers have hit stock markets globally. The MSCI’s World Index is down over 4% over the past month.

“We’ve had something of a buyers’ strike, which is not a phrase I’ve had to use for a while,” said one senior banker who manages IPOs in Europe, preferring to remain anonymous as he is not authorised to speak about his clients.

“The market has turned quite viciously and investors are reluctant to put money to work in IPOs unless they are a complete slam dunk.”

He said that apart from the deal cancellations, a number of IPOs that were being prepared behind the scenes are being postponed.

A few high-profile IPOs are still heading for market, led by Volvo Cars in Sweden, a company that is hoping to tap into the huge appetite for electric vehicle makers and deliver what would be the biggest stock market listing in Europe in 2021.

Bankers also said the Nordic market feels slightly insulated from the travails elsewhere.

Swedish spam blocking app Truecaller completed an IPO that valued it at SEK 19.43 billion ($2.21 billion) and traded up from its list price on Friday.

Norwegian robotics company Autostore is planning an Oslo listing this month that could value it at up to NOK 103.4 billion ($12.04 billion).

Others braving the market turbulence include French cloud computing company OVHCloud, which is due to price its IPO next week, and Russian software group Softline, which is planning a London IPO in the coming weeks.

($1 = 8.7945 Swedish crowns)

($1 = 8.5884 Norwegian crowns)

Graphic: Sinking feeling https://ift.tt/3lpjM9i

(Reporting by Abhinav Ramnarayan and Oliver Hirt. Editing by Jane Merriman)

Source Link Analysis-Europe’s record IPO year has a sting in its tail

David Barret
David Barret

Related posts:

  1. Exiled Ghani apologizes to Afghan people
  2. WHO’s Tedros wins German backing for second term
  3. Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
  4. Lufthansa gets strong investor backing for 2.1 billion euro cash call

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • A Giant Volcano Off The Coast Of Oregon Failed To Erupt On Time. Its New Schedule: 2026
  • Here Are 5 Ways In Which Cancer Treatment Advanced In 2025
  • The First Marine Mammal Driven To Extinction By Humans Disappeared Only 27 Years After Being Discovered
  • The Planet’s Oldest Bee Species Has Become The World’s First Insect To Be Granted Legal Rights
  • Facial Disfiguration: Why Has The Face Been The Target Of Punishment Across Time?
  • The World’s Largest Living Reptile Can “Surf” Over 10 Kilometers To Get Between Islands
  • In 1962, A Geologist Went Into A Cave. 2 Months Later, He’d Accidentally Invented A New Field Of Biology.
  • The Ancient Remains Of A 3-Ton Shark Indicate A New Point Of Origin For Gigantic Lamniform Sharks
  • The Biggest Landslide In Recorded History Happened Quite Recently And Pretty Close To Home
  • Meet The Amami Rabbit, A Goth Bunny That’s Also A Living Fossil
  • The Largest Native Terrestrial Animal In Antarctica Is Both Smaller And Tougher Than You’d Expect
  • The Freaky Reason Why You Should Never Store Tomatoes And Potatoes Together
  • Hominin Vs. Hominid: What’s The Difference?
  • Experimental Alzheimer’s Drug Could Have The Power To Halt Disease Before Symptoms Even Start
  • Al Naslaa: What Made This Enormous Boulder In Saudi Arabia Split In Two? Nobody’s Quite Sure
  • The Amazon Is Entering A “Hypertropical” Climate For The First Time In 10 Million Years
  • What Scientists Saw When They Peered Inside 190-Million-Year-Old Eggs And Recreated Some Of The World’s Oldest Dinosaur Embryos
  • Is 1 Dog Year Really The Same As 7 Human Years?
  • Were Dinosaur Eggs Soft Like A Reptile’s, Or Hard Like A Bird’s?
  • What Causes All The Symptoms Of Long COVID And ME/CFS? The Brainstem Could Be The Key
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version